Niraxx Light Therapeutics Announces New Study Validating Personalized Light Therapy

BLOG “The joint study has confirmed that personalized PBM dosing is key to MDD treatment.” Post Date December 20, 2021 Share

our research partners

We work with world-class research institutions to advance our science. Our partners include Harvard University and Massachusetts General Hospital (MGH). MGH Psychiatry has consistently been ranked #1 in US News & World Report.

5151 California Ave. Suite 100
Irvine, CA 92617

care@niraxx.com

Main Pages

Quick Links

Social Media

Please join our social media to find out the latest news/updates.